Ascentage Pharma Group International (AAPG)
Ascentage Pharma Group International will go public soon. The estimated IPO date is January 24, 2025.
IPO Price
$17.25
Shares Offered
7,325,000
Deal Size
$126.36M
AAPG Revenue
Ascentage Pharma Group International had revenue of 903.03M CNY in the twelve months ending June 30, 2024. In the year 2023, Ascentage Pharma Group International had annual revenue of 221.98M with 5.85% growth.
Revenue (ttm)
903.03M CNY
Revenue Growth
+5.85%
P/S Ratio
11.94
Revenue / Employee
1,505,048 CNY
Employees
600
Market Cap
1.48B undefined
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 221.98M | 12.27M | 5.85% |
| Dec 31, 2022 | 209.71M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAAPG News
- 1 day ago - Ascentage Pharma Announces Pricing of U.S. Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma Group International IPO Registration Document (F-1) - SEC